Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19
Mohamed A. El‐Missiry, Ziad M.A. El-Missiry, Azza I. Othman
Topics & Concepts
MelatoninDiabetes mellitusMedicineImmune systemContext (archaeology)ObesityMetabolic syndromeImmunologyCoronavirusInternal medicineBioinformaticsEndocrinologyCoronavirus disease 2019 (COVID-19)DiseaseBiologyInfectious disease (medical specialty)PaleontologyCircadian rhythm and melatoninTryptophan and brain disordersCOVID-19 and Mental Health